Research and Markets: Acute Ischemic Stroke - Pipeline Review, H2 2013 Report Assists you in Identifying Players of the Most Promising Pipeline

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/7p8rgz/acute_ischemic) has announced the addition of the "Acute Ischemic Stroke - Pipeline Review, H2 2013" report to their offering.

Global Markets Direct's, 'Acute Ischemic Stroke - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Acute Ischemic Stroke, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Ischemic Stroke. Acute Ischemic Stroke - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Acute Ischemic Stroke.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Acute Ischemic Stroke pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Companies Mentioned:

  • D-Pharm Ltd.
  • Daiichi Sankyo Company, Ltd
  • FCB-Pharmicell Co.,Ltd.
  • Gaia BioPharma Limited
  • Glucox Biotech
  • H Lundbeck A/S
  • M's Science Corporation
  • Manipal AcuNova Ltd
  • Mitsubishi Tanabe Pharma Corporation
  • Oxygen Biotherapeutics, Inc.
  • PhytoHealth Corporation
  • Reliance Life Sciences Pvt. Ltd.
  • Remedy Pharmaceuticals, Inc.
  • Sanofi-Aventis
  • Stem Cell Therapeutics Corp.
  • ThromboGenics NV

For more information visit http://www.researchandmarkets.com/research/7p8rgz/acute_ischemic

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System